Evidence map›Paper›PMID 21297615›Full record

ArticleNature2011

DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration.

Hiroki Kaneko, Sami Dridi, Valeria Tarallo, Bradley D Gelfand, Benjamin J Fowler, Won Gil Cho, Mark E Kleinman, Steven L Ponicsan, William W Hauswirth, Vince A Chiodo and 32 more

Abstract read
In one paragraph

Article in Nature, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 393 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
393citing papers in PubMed, 1 pooled it
23.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

393 citing papers in PubMed, 1 synthesis or guideline pooled it, 611 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

333 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

42 authors at 17 institutions in 4 countries.

Hiroki KanekoDepartment of Ophthalmology & Visual Sciences, University of Kentucky, Lexington, Kentucky 40506, USA.
Sami Dridi
Valeria Tarallo
Bradley D Gelfand
Benjamin J Fowler
Won Gil Cho
Mark E Kleinman
Steven L Ponicsan
William W Hauswirth
Vince A Chiodo
Katalin Karikó
Jae Wook Yoo
Dong-ki Lee
Majda Hadziahmetovic
Ying Song
Smita Misra
Gautam Chaudhuri
Frank W Buaas
Robert E Braun
David R Hinton
Qing Zhang
Hans E Grossniklaus
Jan M Provis
Michele C Madigan
Ann H Milam
Nikki L Justice
Romulo J C Albuquerque
Alexander D Blandford
Sasha Bogdanovich
Yoshio Hirano
Jassir Witta
Elaine Fuchs
Dan R Littman
Balamurali K Ambati
Charles M Rudin
Mark M W Chong
Patrick Provost
Jennifer F Kugel
James A Goodrich
Joshua L Dunaief
Judit Z Baffi
Jayakrishna Ambati
University of Kentucky · USPenn Presbyterian Medical Center · USUniversity of Colorado Boulder · USEmory University · USHoward Hughes Medical Institute · USJackson Laboratory · USMeharry Medical College · USSungkyunkwan University · KRUniversity of Florida · USUniversity of Pennsylvania · USAustralian National University · AUJohns Hopkins University · USUniversité Laval · CAUniversity of Southern California · USUniversity of Utah · USUNSW Sydney · AUWalter and Eliza Hall Institute of Medical Research · AU

Funding

P30-Core Grant for Vision Research Core CP30EY006360 · NEI · EMORY UNIVERSITY · PI BOATRIGHT, JEFFREY H · 1986 to 2025
$15.3M
University of Utah, Core Vision Research GrantP30EY014800 · NEI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI PAUL STEVEN BERNSTEIN · 2005 to 2026
$14.6M
Gene Therapy for Leber Congenital AmaurosisU10EY013729 · NEI · UNIVERSITY OF FLORIDA · PI HAUSWIRTH, WILLIAM W · 2001 to 2005
$11.5M
Retinal Iron Transport in Health and DiseaseR01EY015240 · NEI · UNIVERSITY OF PENNSYLVANIA · PI JOSHUA L DUNAIEF · 2004 to 2026
$10.4M
VISION RESEARCHP30EY003040 · NEI · DOHENY EYE INSTITUTE · PI SUN, DEMING · 1985 to 2013
$7.0M
EXPERIMENTAL APPROACH TO MACULOPATHYR01EY001545 · NEI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HINTON, DAVID R. · 1985 to 2016
$6.0M
VISION RESEARCH COREP30EY008571 · NEI · UNIVERSITY OF FLORIDA · PI HAUSWIRTH, WILLIAM W · 1990 to 2010
$5.5M
The Role of Soluble Flt-1 and Raver2 in Ocular Vascular DemarcationsR01EY017950 · NEI · UNIVERSITY OF UTAH · PI AMBATI, BALAMURALI K · 2008 to 2021
$5.2M
Regulation of RNA polymerase ll by small RNAsR01GM068414 · NIGMS · UNIVERSITY OF COLORADO AT BOULDER · PI GOODRICH, JAMES · 2003 to 2018
$5.1M
RETINAL GENE DELIVERY BY ADENO-ASSOCIATED VIRUSR01EY011123 · NEI · UNIVERSITY OF FLORIDA · PI HAUSWIRTH, WILLIAM W · 1995 to 2009
$3.7M
Intraceptor Interference of VEGF PathwaysR01EY017182 · NEI · UNIVERSITY OF UTAH · PI AMBATI, BALAMURALI K · 2007 to 2017
$3.6M
TRANSLATIONAL REGULATION OF THE PROTAMINE 1 GENER01HD027215 · NICHD · UNIVERSITY OF WASHINGTON · PI BRAUN, ROBERT E · 1990 to 2010
$3.0M
Howard Hughes Medical InstituteNEI NIH HHS NIHU10EY013729NEI NIH HHS P30EY003040NEI NIH HHS P30 EY006360NEI NIH HHS P30EY008571NEI NIH HHS P30 EY014800NEI NIH HHS P30 EY021721NEI NIH HHS P30EY06360NEI NIH HHS R01EY001545NEI NIH HHS R01EY011123NEI NIH HHS R01EY015240NEI NIH HHS R01EY015422NEI NIH HHS R01EY017182NEI NIH HHS R01EY017950NEI NIH HHS R01 EY018350NEI NIH HHS R01EY018350NEI NIH HHS R01 EY018836NEI NIH HHS R01EY018836NEI NIH HHS R01 EY020672NEI NIH HHS R01EY020672NEI NIH HHS R21 EY019778NEI NIH HHS R21EY019778NEI NIH HHS RC1 EY020442NEI NIH HHS RC1EY020442NHLBI NIH HHS T32HL091812NIAID NIH HHS R21AI076757NICHD NIH HHS R01HD027215NIGMS NIH HHS R01GM068414
6 · The paper itself

Abstract

Geographic atrophy (GA), an untreatable advanced form of age-related macular degeneration, results from retinal pigmented epithelium (RPE) cell degeneration. Here we show that the microRNA (miRNA)-processing enzyme DICER1 is reduced in the RPE of humans with GA, and that conditional ablation of Dicer1, but not seven other miRNA-processing enzymes, induces RPE degeneration in mice. DICER1 knockdown induces accumulation of Alu RNA in human RPE cells and Alu-like B1 and B2 RNAs in mouse RPE. Alu RNA is increased in the RPE of humans with GA, and this pathogenic RNA induces human RPE cytotoxicity and RPE degeneration in mice. Antisense oligonucleotides targeting Alu/B1/B2 RNAs prevent DICER1 depletion-induced RPE degeneration despite global miRNA downregulation. DICER1 degrades Alu RNA, and this digested Alu RNA cannot induce RPE degeneration in mice. These findings reveal a miRNA-independent cell survival function for DICER1 involving retrotransposon transcript degradation, show that Alu RNA can directly cause human pathology, and identify new targets for a major cause of blindness.

Indexed as

Alu ElementsAnimalsCell DeathCells, CulturedCell SurvivalDEAD-box RNA HelicasesGene Knockdown TechniquesHumansMacular DegenerationMiceMicroRNAsMolecular Sequence DataOligonucleotides, AntisensePhenotypeRetinal Pigment EpitheliumRibonuclease IIIDEAD-box RNA HelicasesDICER1 protein, humanMicroRNAsOligonucleotides, AntisenseRibonuclease IIIRNA

Identifiers

PMID21297615
PMCPMC3077055
OpenAlexW2085350682

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.